REFRACTORY LEUKEMIA

Clinical trials for REFRACTORY LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY LEUKEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for tough leukemias: experimental drug combo enters human testing

Disease control Ongoing

This early-phase trial tests a new drug called tegavivint, combined with decitabine, in 9 adults with leukemia that has come back or not responded to standard treatments. The goal is to find the safest dose and see if the combination can control the disease. Participants must hav…

Matched conditions: REFRACTORY LEUKEMIA

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 01, 2026 15:59 UTC

REFRACTORY LEUKEMIA

Get alerted when new REFRACTORY LEUKEMIA trials appear

New hope for tough leukemias: experimental drug combo enters human testing